Annual meeting of the European Influenza Surveillance Network, 2015
The annual meeting of the European Influenza Surveillance Network brought together representatives from the 31 EU/EEA Member States as well as participants from other countries.
The ECDC annual meeting of the European Influenza Surveillance Network (EISN) prepared in collaboration with the EISN Coordination Committee, brought together epidemiological and virological surveillance contact points and representatives from reference laboratories from the 31 EU/EEA Member States as well as participants from EU pre-accession countries, Eastern European Neighbourhood Policy partner countries, the WHO Regional Office for Europe, and involved international institutions.
The meeting focused on new developments in influenza surveillance and in seasonal influenza vaccination programmes. It served as a forum for analyzing prevalence of A(H3N2) and B drifted viruses and their consequences, and provided an update with regard to outbreaks of avian influenza and other emerging respiratory pathogens around the world. A presentation was also given on global infectious disease governance, and its previous and expected alterations.
The 2014-15 season had seen a large dominance of A(H3N2) in almost all countries and an increasing dominance of B viruses when A(H3N2) declined. There had also been antigenic and genetic drift of A(H3N2) that resulted in antigenic properties dissimilar to the 2014–2015 vaccine virus and very low vaccine effectiveness. Overall the season had been severe.
- It was agreed that a common tool to assess influenza severity in seasonal influenza epidemics should be used, either the WHO Pandemic Influenza Severity Assessment (PISA) tool or an adaptation of it. Additionally, there was broad agreement that RSV surveillance will be required to document the impact of RSV vaccines that are being developed.
- There was also overall agreement that strain-based influenza reporting should continue where established, and that weekly collection of aggregated data on influenza isolated specimens was not necessary. Furthermore, there was strong support for the development of on-line learning materials for laboratory techniques.
It was noted that highly pathogenic avian influenza (HPAI) outbreaks of H5N1 and H5N8 had occurred in the WHO European Region, an important increase of human H5N1 cases was observed in Egypt during the last half-year, and an increased endemicity of H7N9 in poultry in China with an increasing number of human cases. Therefore preparedness of veterinary and public health authorities would be required.
6th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting
6 Jun 2018 to 8 Jun 2018 - The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe will take place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants are epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting is by invitation only.
ECDC Expert meeting on non-pharmaceutical countermeasures for Pandemic flu
16 May 2018 to 17 May 2018 - The meeting will focus on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.
ECDC ENLabCap consultation meeting with EU enlargement countries
1 Feb 2018 to 2 Feb 2018 - Overall aim of this regional ENLabCap consultation workshop is to discuss the adjustments proposed to the current EULabCap tool and agree on those needed to adapt it for the EU enlargement countries.